5 Stocks Trending Among Analysts: ON Semiconductor, Block, Digital Turbine, RingCentral, Vertex

Analysts' ratings and recommendations for ON Semiconductor, Block, Digital Turbine, RingCentral, and Vertex Pharmaceuticals. ON Semiconductor was downgraded to Hold due to muted recovery in sales and gross margins, while Block was downgraded to Hold due to factored-in improvements in its services. Digital Turbine was upgraded to Hold with a promising turnaround, and RingCentral was upgraded to Buy with strong second-quarter results and potential for AI-driven product enhancements. Vertex Pharmaceuticals was upgraded to Buy with a robust core business and promising pipeline outside of its pain program.

Analysts have recently released updated ratings and recommendations for several key tech stocks, reflecting their latest assessments of company performance and future prospects. Here's a breakdown of the key changes:

ON Semiconductor (NASDAQ:ON)
ON Semiconductor was downgraded to Hold by BofA Securities, citing concerns about the company's recovery trajectory. The downgrade follows muted sales recovery, including missed industrial sales targets and ongoing exits from non-core segments. BofA lowered its price target to $56.00 from $70.00, acknowledging the company's strong financial health but expecting sales growth to be closer to 5% year-over-year in 2026 compared to the consensus estimate of 10% [1].

Block (SQ)
Morgan Stanley downgraded Block to Equal-weight from Overweight, citing valuation concerns and elevated investor expectations. The bank noted that Block's stock is trading at $76, which is above its price target of $73. Despite expecting modest acceleration in Square and Cash App growth, Morgan Stanley prefers Chime (CHYM) over Block in the U.S. fintech space due to better execution and customer attachment [3].

Digital Turbine (NASDAQ:APPS)
Digital Turbine was upgraded to Hold by Bank of America, raising its target price from $4.50 to $5.50. The upgrade comes after the company reported a net loss of $0.05 earnings per share for the last quarter, missing the consensus estimate but exceeding revenue expectations. Other analysts, such as Wall Street Zen and Craig Hallum, also boosted their ratings and target prices, reflecting optimism about the company's turnaround potential [4].

RingCentral (RNG)
RingCentral was upgraded to Buy by several analysts, citing strong second-quarter results and potential for AI-driven product enhancements. The company reported revenue of $399.8 million, up 14% year-over-year, and adjusted earnings per share of $0.16, up 22% year-over-year. Analysts expect RingCentral to benefit from increased demand for remote work and collaboration tools [5].

Vertex Pharmaceuticals (VRTX)
Vertex Pharmaceuticals was upgraded to Buy by multiple analysts, highlighting the company's robust core business and promising pipeline outside of its pain program. The upgrade comes after the company reported strong second-quarter results, with revenue of $2.4 billion, up 21% year-over-year, and adjusted earnings per share of $1.11, up 16% year-over-year. Analysts expect Vertex to continue driving growth through its pipeline of innovative therapies [6].

These updates reflect a range of analyst opinions on the performance and future prospects of these companies. Investors should carefully consider these ratings and recommendations when making investment decisions.

References:
[1] https://www.investing.com/news/analyst-ratings/on-semiconductor-stock-rating-downgraded-by-bofa-on-weak-recovery-outlook-93CH-4168969
[2] https://seekingalpha.com/news/4478406-on-semiconductor-gets-rating-cut-at-bofa-after-q2-results
[3] https://finance.yahoo.com/news/morgan-stanley-cuts-block-rating-123100201.html
[4] https://www.marketbeat.com/instant-alerts/digital-turbine-nasdaqapps-rating-increased-to-neutral-at-bank-of-america-2025-08-06/
[5] https://www.marketbeat.com/investing/stocks/ringcentral-inc-rng/
[6] https://www.marketbeat.com/investing/stocks/vertex-pharmaceuticals-inc-vrtx/